Report Type: Therapy Reports
Report Category: Gastrointestinal
Report Subcategory: Global Non-alcoholic Steatohepatitis Market – Industry Trends and Forecast to 2030
Price: $2999.00
Date: December 2021
Non-Alcoholic Steatohepatitis or NASH: Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Non-Alcoholic Steatohepatitis or NASH
Non-Alcoholic Steatohepatitis (NASH) is a condition in which there is an accumulation of liver fat in people who drink little or no alcohol causing inflammation of liver.

Top 10 Companies:
F. Hoffmann-La Roche Ltd
Pfizer Inc
Novartis AG
Merck & Co Inc
GlaxoSmithKline Plc
Mitsubishi Chemical Holdings Corp
Takeda Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Amgen Inc
Gilead Sciences Inc

Table of Contents: 

• Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market - Summary
• Industry Outlook
• Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market - by Type
• Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market - by Industry VerticalsGlobal Non-Alcoholic Steatohepatitis (NASH) Biomarker Market - Regional Outlook
• Competitive Landscape
• Research Methodology & Scope